Name

FUJIYOSHI Masachika

Affiliation

Tottori University Hospital , Division of Pharmacy

Title

Associate Professor

Research areas, keyword

Clinical pharmacokinetics

Research Field (grants-in-aid-for-scientific-research classification)

• Clinical pharmaceutical science

Acceptable Theme for Cooperative Research

• Individual optimization of drug therapy through highly sensitive quantification using LC-MS/MS , Cooperative Research with Other Research Organization Including Private (industrial) Sectors , Cooperative Research

Consultation field

• quantitative analysis

Research Achievement (Published Thesis)

• Significance of UGT1A6, UGT1A9, and UGT2B7 genetic variants and their mRNA expressions in the clinical outcome of renal cell carcinoma. , J. Matsumoto, A. Nishimoto, S. Watari, H. Ueki, S. Shiromizu, N. Iwata, T. Takeda, S. Ushio, M. Kajizono, M. Fujiyoshi, T. Koyama, M. Araki, K. Wada, Y. Zamami, Y. Nasu, N. Ariyoshi , Molecular and Cellular Biochemistry. , 2022.12 , There is Review , The Multiple Authorship , English

• Relevance of CYP3A5 Expression on the Clinical Outcome of Patients With Renal Cell Carcinoma , JUN MATSUMOTO, YUMI KOTERA, SHOGO WATARI, KOICHI TAKEUCHI, HIDEO UEKI, TOSHIHIRO KOYAMA, KOICHIRO WADA, MASACHIKA FUJIYOSHI, YASUTOMO NASU, NORITAKA ARIYOSHI , Anticancer Research , vol.41 (5) (p.2511 - 2521) , 2021.05 , There is Review , The Multiple Authorship , English

• Analysis of the acrolein-modified sites of apolipoprotein B-100 in LDL. , M. Kobayashi, K. Watanabe, T. Suzuki, N. Dohmae, M. Fujiyoshi, M. Uchida, T. Suzuki, K. Igarashi, I. Ishii , Biochim Biophys Acta Mol Cell Biol Lipids , vol.1866 (1) (p.158809) , 2021.01 , There is Review , The Multiple Authorship , English

• Population Pharmacokinetics of Vancomycin Under Continuous Renal Replacement Therapy Using a Polymethylmethacrylate Hemofilter. , Shingo Yamazaki, Mizuki Tatebe, Masachika Fujiyoshi, Noriyuki Hattori, Tatsuya Suzuki, Hirokazu Takatsuka, Masashi Uchida, Takaaki Suzuki, Itsuko Ishii , Therapeutic drug monitoring , vol.42 (3) (p.452 - 459) , 2020.06 , There is Review , The Multiple Authorship , English

• Effect of CYP3A5*3 genetic variant on the metabolism of direct-acting antivirals in vitro: a different effect on asunaprevir versus daclatasvir and beclabuvir. , Jun Matsumoto, Su Nwe San, Masachika Fujiyoshi, Ayano Kawauchi, Natsumi Chiba, Ran Tagai, Ryoko Sanbe, Shiho Yanaka, Hiroaki Sakaue, Yoshinori Kato, Hiroyoshi Nakamura, Harumi Yamada, Noritaka Ariyoshi , Journal of human genetics , vol.65 (2) (p.143 - 153) , 2020.01 , There is Review , The Multiple Authorship , English

display all >>

Scientific Research Funds Acquisition Results

• Promotion proper use of sleeping medications by TDM and its application in community pharmacies , 2022.04 - , 2022 , (New)

Updated on 2025/08/06